PP14 Recombinant Human Erythropoietin For Sickle Cell Disease And Brazilian Healthcare System Sustainability: Cost-Effectiveness And Budget Impact Analysis

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	International Journal of Technology Assessment in Health Care vol. 40, no. S1 (Jan 2025), p. S59
Kaituhi matua:	Gargano, Ludmila
Ētahi atu kaituhi:	Lobo, Clarisse, Haliton Alves De Oliveira, Lucchetta, Rosa
I whakaputaina:	Cambridge University Press
Ngā marau:	Budgets Hemoglobin Blood transfusion Blood transfusions Sustainability Technology assessment Epidemiology Cost benefit analysis Sickle cell disease Effectiveness Impact analysis Cost analysis Patients Cost control Erythropoietin Decision trees Rare diseases Erythropoiesis Health technology assessment Transfusion Renal function Social
Urunga tuihono:	Citation/Abstract Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!